Probing PAC1 receptor activation across species with an engineered sensor

Reto B Cola,Salome N Niethammer,Preethi Rajamannar,Andrea Gresch,Musadiq A Bhat,Kevin Assoumou,Elyse T Williams,Patrick Hauck,Nina Hartrampf,Dietmar Benke,Miriam Stoeber,Gil Levkowitz,Sarah Melzer,Tommaso Patriarchi
DOI: https://doi.org/10.1101/2024.02.06.579048
2024-06-02
Abstract:Class-B1 G protein-coupled receptors (GPCRs) are an important family of clinically relevant drug targets that remain difficult to investigate via high-throughput screening and in animal models. Here, we engineered PAClight1P78A, a novel genetically-encoded sensor based on a class-B1 GPCR (the human PAC1 receptor, hmPAC1R) endowed with high dynamic range (deltaF/F0 = 1100%), excellent ligand selectivity and rapid activation kinetics (TON = 1.15 sec). To showcase the utility of this tool for in vitro applications, we thoroughly characterized and compared its expression, brightness and performance between PAClight1P78A transfected and stably-expressing cells. Demonstrating its use in animal models, we show robust expression and fluorescence responses upon exogenous ligand application ex vivo and in vivo in mice, as well as in living zebrafish larvae. Thus, the new GPCR-based sensor can be used for a wide range of applications across the life sciences empowering both basic research and drug development efforts.
Neuroscience
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop a new type of genetically - encoded sensor based on the human PAC1 receptor (hmPAC1R) for direct optical detection of G - protein - coupled receptor (GPCR) activation with high sensitivity and spatio - temporal resolution. Specifically, the researchers designed an ultrasensitive indicator named PAClight1 P78A through protein engineering methods, aiming to overcome the difficulties of Class - B1 GPCR (an important class of clinically relevant drug targets) in high - throughput screening and animal model studies. ### Main Objectives: 1. **Develop a High - Sensitivity Sensor**: - Design and optimize a genetically - encoded sensor PAClight1 P78A based on the human PAC1 receptor, making it have a high dynamic range (ΔF/F₀ = 1100%), excellent ligand selectivity, and rapid activation kinetics (τON = 1.15 seconds). 2. **Verify the Sensor's Performance**: - Characterize in detail the expression, brightness, and performance of PAClight1 P78A in transfected cells and stably - expressing cells through in vitro experiments. - Test its expression and fluorescence response in acute mouse brain slices and live zebrafish larvae to verify its application potential in animal models. 3. **Improve the Efficiency of Drug Screening and Basic Research**: - Provide a powerful tool for drug screening and life - science research by developing this new GPCR - based sensor, reducing time and cost. ### Specific Problems Solved: - **Challenges in High - Throughput Screening**: Class - B1 GPCRs are difficult to study in high - throughput screening because their activation processes are complex and difficult to detect. - **Application in Animal Models**: The application of existing GPCR sensors in animal models is limited, and the design of PAClight1 P78A aims to overcome this limitation, enabling real - time monitoring in live animals. - **Bottlenecks in Drug Development**: Accelerate drug development and functional testing for the PAC1R pathway by providing a highly sensitive and specific sensor. ### Key Innovation Points: - **High Dynamic Range**: The fluorescence response range of PAClight1 P78A is as high as 1100%, much higher than that of existing sensors. - **Ligand Selectivity**: Through specific mutations (such as P78A), PAClight1 P78A is highly selective for PACAP and does not respond to VIP. - **Rapid Activation Kinetics**: The activation time constant of the sensor is only 1.15 seconds, which is suitable for real - time monitoring. In conclusion, this paper solves the technical problems of Class - B1 GPCR in high - throughput screening and animal model studies by developing the PAClight1 P78A sensor, providing new tools for drug development and basic research.